Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Celldex Therapeutics Price to Free Cash Flow Ratio 2006-2019 | CLDX

Historical price to free cash flow ratio values for Celldex Therapeutics (CLDX) since 2006.
  
Celldex Therapeutics Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2019-12-13 2.16 0.00
2019-09-30 2.13 $-12.47 0.00
2019-06-30 2.68 $-15.62 0.00
2019-03-31 4.92 $-18.53 0.00
2018-12-31 2.97 $-20.46 0.00
2018-09-30 6.77 $-25.08 0.00
2018-06-30 7.55 $-29.05 0.00
2018-03-31 34.95 $-31.24 0.00
2017-12-31 42.60 $-32.58 0.00
2017-09-30 42.90 $-37.81 0.00
2017-06-30 37.05 $-42.45 0.00
2017-03-31 54.15 $-46.21 0.00
2016-12-31 53.10 $-47.23 0.00
2016-09-30 60.60 $-46.16 0.00
2016-06-30 65.85 $-45.67 0.00
2016-03-31 56.70 $-44.25 0.00
2015-12-31 235.20 $-44.40 0.00
2015-09-30 158.10 $-45.72 0.00
2015-06-30 378.30 $-45.69 0.00
2015-03-31 418.05 $-45.52 0.00
2014-12-31 273.75 $-45.37 0.00
2014-09-30 194.40 $-41.52 0.00
2014-06-30 244.80 $-38.03 0.00
2014-03-31 265.05 $-35.69 0.00
2013-12-31 363.15 $-33.83 0.00
2013-09-30 531.45 $-33.27 0.00
2013-06-30 234.15 $-32.36 0.00
2013-03-31 173.70 $-32.16 0.00
2012-12-31 100.65 $-32.70 0.00
2012-09-30 94.50 $-33.45 0.00
2012-06-30 77.63 $-33.31 0.00
2012-03-31 76.35 $-34.19 0.00
2011-12-31 39.00 $-34.34 0.00
2011-09-30 34.28 $-35.88 0.00
2011-06-30 53.25 $-39.03 0.00
2011-03-31 60.30 $-40.01 0.00
2010-12-31 61.80 $-39.26 0.00
2010-09-30 60.00 $-46.37 0.00
2010-06-30 68.40 $-51.75 0.00
2010-03-31 92.10 $-55.69 0.00
2009-12-31 70.05 $-56.82 0.00
2009-09-30 82.35 $-17.66 0.00
2009-06-30 117.30 $15.38 7.63
2009-03-31 97.65 $53.08 1.84
2008-12-31 118.80 $51.28 2.32
2008-09-30 174.45 $17.86 9.77
2008-06-30 218.40 $-8.13 0.00
2008-03-31 147.00 $-42.38 0.00
2007-12-31 90.00 $-40.55 0.00
2007-09-30 100.80 $-27.17 0.00
2007-06-30 149.40 $40.20 3.72
2007-03-31 262.80 $122.24 2.15
2006-12-31 241.20 $215.13 1.12
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.010B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.667B 16.20
CSL (CSLLY) Australia $87.267B 0.00
Gilead Sciences (GILD) United States $83.209B 10.31
Vertex Pharmaceuticals (VRTX) United States $56.311B 57.47
Biogen (BIIB) United States $53.561B 9.19
Illumina (ILMN) United States $47.734B 52.37
Regeneron Pharmaceuticals (REGN) United States $41.329B 18.10
Alexion Pharmaceuticals (ALXN) United States $24.435B 12.07
Incyte (INCY) United States $19.711B 45.76
Seattle Genetics (SGEN) United States $19.516B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.617B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.401B 0.00
Genmab (GNMSF) Denmark $13.473B 59.51
Alnylam Pharmaceuticals (ALNY) United States $13.127B 0.00
Galapagos (GLPG) Belgium $11.469B 29.55
Exact Sciences (EXAS) United States $11.321B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.822B 51.94
Sarepta Therapeutics (SRPT) United States $9.843B 0.00
QIAGEN (QGEN) Netherlands $9.282B 30.26
Amarin (AMRN) Ireland $8.616B 0.00
BeiGene (BGNE) Cayman Islands $8.453B 0.00
Bio-Techne Corp (TECH) United States $8.119B 54.34
BioNTech SE (BNTX) Germany $7.342B 0.00
Guardant Health (GH) United States $7.127B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.829B 0.00
Medicines (MDCO) United States $6.714B 0.00
Reata Pharmaceuticals (RETA) United States $6.259B 0.00
Moderna (MRNA) United States $6.205B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.151B 15.64
ARGENX SE-ADR (ARGX) Netherlands $5.987B 0.00
Exelixis (EXEL) United States $5.415B 15.23
Bluebird Bio (BLUE) United States $4.966B 0.00
Ascendis Pharma (ASND) Denmark $4.854B 0.00
Repligen (RGEN) United States $4.612B 83.58
China Biologic Products (CBPO) China $4.605B 25.94
MorphoSys AG (MOR) Germany $4.485B 0.00
Mirati Therapeutics (MRTX) United States $4.427B 0.00
Spark Therapeutics (ONCE) United States $4.266B 0.00
Immunomedics (IMMU) United States $3.997B 0.00
Adaptive Biotechnologies (ADPT) United States $3.755B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.737B 0.00
Blueprint Medicines (BPMC) United States $3.653B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.608B 0.00
Alkermes (ALKS) Ireland $3.287B 0.00
UniQure (QURE) Netherlands $3.227B 0.00
MyoKardia (MYOK) United States $3.083B 0.00
Genmab (GMAB) Denmark $2.854B 5.88
Halozyme Therapeutics (HALO) United States $2.781B 0.00
NeoGenomics (NEO) United States $2.758B 146.78
Emergent Biosolutions (EBS) United States $2.683B 26.65
Acceleron Pharma (XLRN) United States $2.679B 0.00
Zai Lab (ZLAB) China $2.502B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.469B 0.00
Amicus Therapeutics (FOLD) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.356B 5.48
RA PHARMCTL INC (RARX) United States $2.225B 0.00
Insmed (INSM) United States $2.074B 0.00
Myriad Genetics (MYGN) United States $1.903B 28.11
Ligand Pharmaceuticals (LGND) United States $1.862B 35.82
Dicerna Pharmaceuticals (DRNA) United States $1.833B 0.00
Denali Therapeutics (DNLI) United States $1.815B 0.00
Akcea Therapeutics (AKCA) United States $1.812B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Principia Biopharma (PRNB) United States $1.630B 0.00
Epizyme (EPZM) United States $1.613B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Editas Medicine (EDIT) United States $1.534B 0.00
Arvinas (ARVN) United States $1.435B 0.00
Fate Therapeutics (FATE) United States $1.420B 0.00
Innoviva (INVA) United States $1.394B 4.11
Alector (ALEC) United States $1.393B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.371B 0.00
Coherus BioSciences (CHRS) United States $1.299B 0.00
WAVE Life Sciences (WVE) Singapore $1.289B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Athenex (ATNX) United States $1.128B 0.00
Zealand Pharma (ZEAL) Denmark $1.015B 0.00
Pharming Group (PHGUF) Netherlands $1.013B 0.00
Sangamo Therapeutics (SGMO) United States $0.987B 0.00
Codexis (CDXS) United States $0.925B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.892B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.892B 7.50
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Twist Bioscience (TWST) United States $0.870B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.841B 0.00
Intellia Therapeutics (NTLA) United States $0.807B 0.00
Vericel (VCEL) United States $0.788B 294.00
MiMedx (MDXG) United States $0.782B 0.00
DBV Technologies S.A (DBVT) France $0.780B 0.00
Anika Therapeutics (ANIK) United States $0.758B 24.61
ANI Pharmaceuticals (ANIP) United States $0.739B 12.60
Heska (HSKA) United States $0.732B 186.92
Revance Therapeutics (RVNC) United States $0.721B 0.00
Intra-Cellular Therapies (ITCI) United States $0.709B 0.00
Clovis Oncology (CLVS) United States $0.705B 0.00
Adverum Biotechnologies (ADVM) United States $0.681B 0.00
Cellectis S.A (CLLS) France $0.677B 0.00
UROGEN PHARMA (URGN) United States $0.676B 0.00
Mesoblast (MESO) Australia $0.670B 0.00
Sorrento Therapeutics (SRNE) United States $0.670B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Cytokineticsorporated (CYTK) United States $0.629B 0.00
GENFIT S.A (GNFT) France $0.628B 0.00
Retrophin (RTRX) United States $0.616B 0.00
Kadmon Holdings (KDMN) United States $0.613B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
PHARMA MAR SA (PHMMF) Spain $0.584B 0.00
Dynavax Technologies (DVAX) United States $0.580B 0.00
AC Immune SA (ACIU) Switzerland $0.577B 13.34
BioDelivery Sciences (BDSI) United States $0.573B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Agenus (AGEN) United States $0.527B 0.00
Precision BioSciences (DTIL) United States $0.523B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.516B 3.57
Prothena (PRTA) Ireland $0.513B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.508B 0.00
Stemline Therapeutics (STML) United States $0.504B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.395B 0.00
Bellus Health (BLU) Canada $0.387B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
AMAG Pharmaceuticals (AMAG) United States $0.378B 0.00
OSMOTICA PHARM (OSMT) United States $0.370B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.344B 0.00
Gritstone Oncology (GRTS) United States $0.331B 0.00
Starpharma Holdings (SPHRY) Australia $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.325B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Kindred Biosciences (KIN) United States $0.319B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.314B 0.00
Cue Biopharma (CUE) United States $0.312B 0.00
Scholar Rock Holding (SRRK) United States $0.305B 0.00
Geron (GERN) United States $0.300B 0.00
Seres Therapeutics (MCRB) United States $0.294B 0.00
Kamada (KMDA) Israel $0.294B 8.58
Compugen (CGEN) Israel $0.290B 0.00
NantKwest (NK) United States $0.283B 0.00
MannKind (MNKD) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Inovio Pharmaceuticals (INO) United States $0.272B 0.00
Exicure (XCUR) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
Albireo Pharma (ALBO) United States $0.257B 0.00
IVERIC Bio (ISEE) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.242B 0.00
Senesco Technologies (ELOX) United States $0.239B 0.00
Theratechnologies (THTX) Canada $0.234B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.231B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Proteostasis Therapeutics (PTI) United States $0.217B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
Affimed (AFMD) Germany $0.194B 0.00
Athersys (ATHX) United States $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.190B 0.00
Abeona Therapeutics (ABEO) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Mersana Therapeutics (MRSN) United States $0.178B 0.00
VBI Vaccines (VBIV) United States $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Windtree Therapeutics (WINT) United States $0.151B 0.00
Alcobra (ARCT) United States $0.150B 0.00
Aptinyx (APTX) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.139B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.138B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arbutus Biopharma (ABUS) Canada $0.132B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Nicox SA (NICXF) France $0.125B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.108B 0.00
Novavax (NVAX) United States $0.107B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
Emmaus Life Sciences (EMMA) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.100B 2.67
Verastem (VSTM) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Acorda Therapeutics (ACOR) United States $0.085B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
OvaScience (MLND) United States $0.083B 0.00
Vaccinex (VCNX) United States $0.082B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Trevena (TRVN) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Orgenesis (ORGS) United States $0.046B 2.97
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
Celsion (CLSN) United States $0.037B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
BioCardia (BCDA) United States $0.028B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Soligenix (SNGX) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
CollPlant Holdings (CLGN) Israel $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.003B 0.00